$698 Million is the total value of Hudson Executive Capital LP's 8 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| AKYA | Buy | AKOYA BIOSCIENCES INC | $43,446,000 | +38.1% | 3,697,558 | +51.1% | 6.22% | +56.0% |
| LSYN | Buy | LIBERATED SYNDICATION INC | $10,080,000 | +5.7% | 2,688,000 | +5.7% | 1.44% | +19.3% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| DEUTSCHE BANK AG | 21 | Q3 2023 | 88.0% |
| EAGLE PHARMACEUTICALS INC | 16 | Q4 2019 | 34.5% |
| NATERA INC | 15 | Q4 2022 | 4.6% |
| CARDTRONICS PLC | 14 | Q1 2021 | 43.3% |
| VIEWRAY INC | 14 | Q2 2023 | 8.2% |
| ATRICURE INC | 13 | Q3 2019 | 20.9% |
| CIT GROUP INC | 11 | Q2 2018 | 26.4% |
| TIVITY HEALTH INC | 11 | Q1 2022 | 12.3% |
| CORINDUS VASCULAR ROBOTICS I | 11 | Q3 2019 | 9.7% |
| CANTALOUPE INC | 10 | Q3 2023 | 11.8% |
View Hudson Executive Capital LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| ViewRay, Inc. | July 21, 2023 | 6,752,093 | 3.7% |
| Akoya Biosciences, Inc. | February 07, 2023 | 1,892,204 | 5.0% |
| Liberated Syndication Inc. | March 23, 2022 | 2,400,000 | 8.6% |
| eHealth, Inc. | March 11, 2022 | 750,501 | 2.8% |
| Talkspace, Inc. | November 17, 2021 | 17,980,600 | 11.2% |
| USA TECHNOLOGIES INC | February 26, 2021 | 11,995,765 | 16.9% |
| Cardtronics plc | December 15, 2020 | 8,644,880 | 19.4% |
| TIVITY HEALTH, INC. | May 11, 2020 | 4,795,310 | 9.9% |
| EAGLE PHARMACEUTICALS, INC. | January 16, 2020 | 361,897 | 2.6% |
| Corindus Vascular Robotics, Inc.Sold out | October 31, 2019 | 0 | 0.0% |
View Hudson Executive Capital LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| 144 | 2024-02-21 |
| 4 | 2024-02-21 |
| SC 13D/A | 2024-02-21 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| SC 13D/A | 2023-07-21 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
View Hudson Executive Capital LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.